For instance, circPTPRA suppressed bladder cancer growth and metastasis via downregulation of m6A-modified MYC proto-oncogene, bHLH transcription factor (MYC) and fascin actin-bundling protein 1 (FSCN1) through interacting with IGF2BP1 [19]. The gene discussed is FSCN1; the disease is urinary bladder carcinoma.